Ignite Creation Date:
2025-12-24 @ 5:06 PM
Ignite Modification Date:
2025-12-24 @ 5:06 PM
Study NCT ID:
NCT04336150
Status:
COMPLETED
Last Update Posted:
2024-01-22
First Post:
2020-03-31
Is Possible Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Effectiveness of Different Hypopressive Exercises in Pelvic Floor Dysfunction
Sponsor:
University of Alcala
Organization:
Study Overview
Official Title:
Effectiveness of Different Hypopressive Exercises for Treating Pelvic Floor Dysfunction in Women: Randomized Controlled Trial
Status:
COMPLETED
Status Verified Date:
2024-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
HIPOSPFD
Brief Summary:
The purpose of the study is to compare the efficacy of different modalities of hypopressive exercises and biofeedback with ultrasound in women with pelvic floor dysfunctions, considering the efficacy of the treatment as improving the specific quality of life related to pelvic floor dysfunctions and improvement of the muscular properties of the pelvic floor muscles.
Detailed Description:
Female 18-65 years old
Inclusion Criteria:
Women diagnosed with pelvic floor dysfunction by their doctor. With minimum strength of the pelvic floor muscles of 3 according to Modified Oxford Score
Exclusion Criteria:
Women who are pregnant or women who have had a vaginal or caesarean birth in the past six months.
Women whose PFD is severe and the first indication is surgical (POP-Q grade III-IV prolapses).
Women with only urinary incontinence or fecal urgency. Women with pain in the pelvic-perineal region of 3 cm in the visual analog scale, where a score of 0 cm means no pain, and a score of 10cm, the maximum pain that the participant can imagine.
Women who have received pelvic floor physiotherapy treatment in the last 12 months.
Women who are unable to voluntarily contract the pelvic floor muscles, quantified by the Modified Oxford Score by a score less than or equal to 2.
Women with any pathology that may affect the treatment (neurological, gynecological or urological), or with recurrent urinary infection or hematuria.
Women with cognitive limitations to understand the information, answer the questionnaires, consent and / or participate in the study.
Inclusion Criteria:
Women diagnosed with pelvic floor dysfunction by their doctor. With minimum strength of the pelvic floor muscles of 3 according to Modified Oxford Score
Exclusion Criteria:
Women who are pregnant or women who have had a vaginal or caesarean birth in the past six months.
Women whose PFD is severe and the first indication is surgical (POP-Q grade III-IV prolapses).
Women with only urinary incontinence or fecal urgency. Women with pain in the pelvic-perineal region of 3 cm in the visual analog scale, where a score of 0 cm means no pain, and a score of 10cm, the maximum pain that the participant can imagine.
Women who have received pelvic floor physiotherapy treatment in the last 12 months.
Women who are unable to voluntarily contract the pelvic floor muscles, quantified by the Modified Oxford Score by a score less than or equal to 2.
Women with any pathology that may affect the treatment (neurological, gynecological or urological), or with recurrent urinary infection or hematuria.
Women with cognitive limitations to understand the information, answer the questionnaires, consent and / or participate in the study.
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: